A 71-year-old man is evaluated in the hospital for a transition to comfort-focused care. He has a history of ischemic cardiomyopathy for which a left ventricular assist device (LVAD) was implanted as destination therapy three years ago. Two months ago, he was diagnosed with widely metastatic pancreatic adenocarcinoma and has experienced rapid functional decline. He is now completely bedbound, cachectic, and experiencing poorly controlled abdominal pain despite escalating doses of intravenous opioids. During a family meeting, the patient, who demonstrates clear decision-making capacity, requests to be discharged to home hospice. He also explicitly requests that his LVAD be deactivated once he arrives home, stating, "I am ready to die naturally, and I do not want this machine keeping my body alive anymore." The cardiology team expresses concern that turning off the implanted device is ethically and legally equivalent to physician-assisted suicide. Which of the following is the most appropriate next step in management?
- Arrange for home hospice discharge and coordinate with the palliative team to deactivate the LVAD at the patient's residence.Cevap
- BDecline the deactivation request, as intentionally disabling an internal device that replaces native organ function constitutes active euthanasia.
- CDefer the deactivation until a court-appointed psychiatrist formally confirms the patient is legally competent to refuse life support.
- DTransfer the patient to an inpatient hospice unit, as withdrawal of advanced mechanical circulatory support is prohibited in the home setting.
- EObtain written authorization from the patient's next of kin, as surrogate consent is mandatory when withdrawing destination therapy devices.